Skip to main content

Sources last read

Brand guide · Orforglipron

What is Foundayo?

Foundayo is a daily pill for adults managing weight.

Source for this answer

Source: Current FDA label, checked 2026-09-06

Source: Current FDA label, checked 2026-09-06

Explore Foundayo

Dosage scheduleSee every labeled step from 0.8 mg to 17.2 mg.Side effectsSee common trial results and serious warnings from the current label.Cost and coverageCompare the list price, published cash offers and key limits.

Approved uses

What is Foundayo approved to treat?

Adults with obesity, or with overweight plus at least one related health condition.

Labeled maintenance: The label names no maintenance dose; after 5.5 mg, further increases depend on response and how well people handle it

Not an approved use: For people under 18, the label does not establish use. It advises against taking Foundayo with another GLP-1 receptor agonist.

The product itself

Available forms and strengths

Film-coated tablet

0.8, 2.5, 5.5, 9, 14.5 and 17.2 mg

Bottle of 30 tablets

Key product facts

What matters first

Medicine
Orforglipron
How often
Once daily, at any time of day, with or without food
Starting dose
0.8 mg
Highest labeled dose
17.2 mg

Eli Lilly and Company makes Foundayo under NDA 220934. Foundayo comes as a tablet to swallow whole.

1primary source, each with the day we read it — open the documents used on this page
This is an independent guide to Foundayo, a registered brand name. Eli Lilly and Company does not sponsor or endorse it. This guide explains public FDA records and does not give medical advice.